Skip to Main Content

Paper Details

The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers.
NPJ Breast Cancer
5
2021
FABP5, HER2, HER2-negative primary, HER2-negative primary breast cancers, NEOERIBULIN, RNA, SOLTI-1007, TILs, Tumour, VEGF, breast cancer, eribulin, patient, patients, stromal TILs, tumour, tumour-infiltrating lymphocytes, tumours
Author NameAffiliation
Stephen-John SammutCancer Research UK Cambridge Institute
Stephen-John SammutCambridge University Hospitals NHS Foundation Trust
Rodrigo DienstmannVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital
Isabel T RubioVall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital
Carlos CaldasCancer Research UK Cambridge Institute
Carlos CaldasCambridge University Hospitals NHS Foundation Trust
  • 1 - 6

Datasets

Release 1.2